Publications Oral PD-L1 inhibitor GS-4224 selectively engages PD-L1 high cells and elicits pharmacodynamic responses in patients with advanced solid tumors Checkpoint inhibitors targeting the programmed cell death 1 (PD-1)/programmed cell death 1 ligand… April 11, 2024
Publications Effects of small molecule-induced dimerization on the programmed death ligand 1 protein life cycle Over the last decade, immune checkpoint blockade has emerged as a pillar of… December 9, 2022
